StockData
Surrozen, Inc./DE logo

Surrozen, Inc./DE (SRZN) income statement

SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$31.74+1.76 (+5.87%)

Close on Nov 18, 2026Market cap $373.06MP/E –Yield –

Surrozen, Inc./DE income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-385.3%
Net margin
-2885.3%
Return on equity, FY2025
231.4%

Financial strength

Current ratio
12.14
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1132.4%

Valuation

P/E ratio
–
Price to sales
32.41
Price to book
–
Dividend yield
–

See a number that looks wrong?